Nuclear transcription factor-κB as a target for cancer drug development
Open Access
- 1 June 2002
- journal article
- review article
- Published by Springer Nature in Leukemia
- Vol. 16 (6) , 1053-1068
- https://doi.org/10.1038/sj.leu.2402482
Abstract
Nuclear factor kappa B (NF-κB) is a family of inducible transcription factors found virtually ubiquitously in all cells. Since its discovery by Sen and Baltimore in 1986, much has been discovered about its mechanisms of activation, its target genes, and its function in a variety of human diseases including those related to inflammation, asthma, atherosclerosis, AIDS, septic shock, arthritis, and cancer. Due to its role in a wide variety of diseases, NF-κB has become one of the major targets for drug development. Here, we review our current knowledge of NF-κB, the possible mechanisms of its activation, its potential role in cancer, and various strategies being employed to target the NF-κB signaling pathway for cancer drug development.Keywords
This publication has 254 references indexed in Scilit:
- Pro-apoptotic action of PAR-4 involves inhibition of NF-?B activity and suppression of BCL-2 expressionJournal of Neuroscience Research, 2000
- p300/CBP-Dependent and -Independent Transcriptional Interference between NF-κB RelA and p53Biochemical and Biophysical Research Communications, 2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Ubiquitin-proteasome inhibition enhances apoptosis of human pancreatic cancer cellsSurgery, 1999
- Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelAOncogene, 1999
- Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-κBOncogene, 1999
- Glutathione Downregulates the Phosphorylation of IκB: Autoloop Regulation of the NF-κB-Mediated Expression of NF-κB Subunits by TNF-α in Mouse Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1998
- An Allosteric Drug,o,o′-Bismyristoyl Thiamine Disulfide, Suppresses HIV-1 Replication through Prevention of Nuclear Translocation of both HIV-1 Tat and NF-κBBiochemical and Biophysical Research Communications, 1998
- Cytokine Induced Expression of Porcine Inhibitor of Apoptosis Protein (iap) Family Member Is Regulated by NF-κBBiochemical and Biophysical Research Communications, 1998
- Platelet-Activating Factor (PAF) Positively Auto-Regulates the Expression of Human PAF Receptor Transcript 1 (Leukocyte-Type) Through NF-κBBiochemical and Biophysical Research Communications, 1994